Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page
- Check2 days agoChange DetectedThe page now shows revision v3.5.4, indicating an updated version of the study record and related documents. This appears to be a minor version bump rather than a substantive change to the study content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision metadata has been updated from Revision: v3.5.0 to Revision: v3.5.3, alongside an updated date entry (2026-04-13). This reflects a publication/version refresh of the study record rather than a modification to the trial details or outcomes.SummaryDifference0.2%

- Check38 days agoChange DetectedNew study record updates dated 2026-04-08 and 2026-04-09 were added, and entries for 2026-04-01 and 2026-04-02 were removed.SummaryDifference0.1%

- Check45 days agoChange DetectedTwo additions were recorded on 2026-04-01 and 2026-04-02, and two deletions were recorded on 2026-03-24 and 2026-03-25, updating the study record.SummaryDifference0.1%

- Check52 days agoChange DetectedAdministrative updates were made to the study record on 2026-03-24 and 2026-03-25, with deletions on 2026-03-17 and 2026-03-18.SummaryDifference0.1%

- Check60 days agoChange DetectedAdditions on 2026-03-18 and 2026-03-17 include Revision: v3.5.0. Deletions on 2026-03-11 and 2026-03-10 include Revision: v3.4.3.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.